No response | Response | p value | |
---|---|---|---|
N = 10 | N = 6 | ||
Age, years | 39 (30.5–44.7) | 31.5 (20.5–49.2) | 0.447 |
Sex, male, % | 7 /70%) | 3 (50) | 0.607 |
Obesity BMI ≥ 30, % | 4 (50) | 0 (0) | 0.236 |
BMI, Kg/m2 | 28.9 (25.7–33.7) | 24.2 (23–26.3) | 0.540 |
Abdominal pain, % | 5 (50) | 0 (0) | 0.231 |
Symptoms duration before SeHCAT, months | 16.4 (10.9–26.6) | 15.33 (13.8–6) | 0.302 |
Faecal urgency, % | 2 (22.2) | 2 (33.3) | 1.000 |
Number of stools | 5 (3–6) | 5 (3–7) | 1.000 |
SeHCAT retention, % | 4.5 (1.6–5.6) | 3.5 (0.0–9.6) | 1.000 |
Dose of cholestyramine, grams | 4.5 (2–7.5) | 3 (3–3.7) | 0.661 |
Patients with adverse events, % | 4 (40) | 3 (50) | 1.000 |